You are here
AUXAGEN, INC.
UEI: J74LH5EBZDA9
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A Novel TGF-β Receptor Antagonist to Treat Pulmonary Fibrosis
Amount: $283,567.00DESCRIPTION provided by applicant Pulmonary fibrosis PF including idiopathic PF IPF is a group of progressive incurable lung diseases with high mortality rates PF is characterized by excess ...
SBIRPhase I2016Department of Health and Human Services National Institutes of Health -
TGF-beta Antagonists for Accelerating Wound Healing
Amount: $998,034.00DESCRIPTION (provided by applicant): Every year in the United States, gt1.25 million people suffer from burns, 6.5 million have chronic skin ulcers caused by pressure, venous stasis or diabetes mellit ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
A Therapeutic Agent for Radiation-induced Lung Fibrosis
Amount: $227,692.00DESCRIPTION (provided by applicant): Lung fibrosis, a group of incurable lung diseases with high mortality rates, is characterized by inflammatory cell infiltration, fibroblast proliferation, and exce ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Novel Therapeutic Agents for Diabetic Ulcers
Amount: $182,189.00DESCRIPTION (provided by applicant): Diabetes mellitus afflicts 20.8 million people, or 7% of the population, in the United States. Fifteen percent, or 2.4 million people, will develop diabetic foot u ...
STTRPhase I2008Department of Health and Human Services National Institutes of Health -
Novel Antagonists for Ameliorating Pulmonary Fibrosis
Amount: $199,467.00DESCRIPTION (provided by applicant): Pulmonary fibrosis, a group of incurable lung diseases with high mortality rates, is characterized by inflammatory cell infiltration, fibroblast proliferation, and ...
STTRPhase I2007Department of Health and Human Services National Institutes of Health -
TGF-Beta Antagonists for Accelerating Wound Healing
Amount: $175,480.00DESCRIPTION (provided by applicant): Impaired or abnormal wound healing is a major health problem for elderly, diabetic, immunosuppressed, immobilized, burn-injured and keloid individuals. Every year ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health